Vitamin D and COVID-19: Role of ACE2, age, gender, and ethnicity

J Med Virol. 2021 Sep;93(9):5285-5294. doi: 10.1002/jmv.27075. Epub 2021 May 19.

Abstract

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, disproportionally targets older people, particularly men, ethnic minorities, and individuals with underlying diseases such as compromised immune system, cardiovascular disease, and diabetes. The discrepancy in COVID-19 incidence and severity is multifaceted and likely involves biological, social, as well as nutritional status. Vitamin D deficiency, notably common in Black and Brown people and elderly, is associated with an increased susceptibility to many of the diseases comorbid with COVID-19. Vitamin D deficiency can cause over-activation of the pulmonary renin-angiotensin system (RAS) leading to the respiratory syndrome. RAS is regulated in part at least by angiotensin-converting enzyme 2 (ACE2), which also acts as a primary receptor for SARS-CoV-2 entry into the cells. Hence, vitamin D deficiency can exacerbate COVID-19, via its effects on ACE2. In this review we focus on influence of age, gender, and ethnicity on vitamin D-ACE2 interaction and susceptibility to COVID-19.

Keywords: SARS-CoV-2; angiotensin-converting enzyme 2 (ACE2); co-morbidity-COVID-19; cytokine Storm; vitamin D deficiency.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Age Factors
  • Angiotensin-Converting Enzyme 2 / immunology*
  • COVID-19 / epidemiology*
  • Ethnicity
  • Humans
  • Risk Factors
  • Sex Factors
  • Vitamin D Deficiency*

Substances

  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2